Diamond Biotechnology Co., Ltd (TPEX:6815)
Taiwan · Delayed Price · Currency is TWD 26.90
-0.15 (-0.55%)
At close: Jul 9, 2026
Diamond Biotechnology Market Cap
Diamond Biotechnology has a market cap or net worth of 1.07 billion as of July 9, 2026. Its market cap has decreased by -46.61% in one year.
Market Cap
1.07B
Enterprise Value
1.09B
Revenue
501.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.90
Market Cap Chart
Since January 29, 2021, Diamond Biotechnology's market cap has decreased from 1.68B to 1.07B, a decrease of -36.45%. That is a compound annual growth rate of -7.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 1.07B | -57.34% |
| Dec 31, 2025 | 2.50B | -7.50% |
| Dec 31, 2024 | 2.71B | 12.05% |
| Dec 29, 2023 | 2.42B | 179.34% |
| Dec 30, 2022 | 864.86M | -11.33% |
| Dec 30, 2021 | 975.37M | -41.97% |
| Jan 29, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Taiwan Biomaterial | 1.65B |
| Bioptik Technology Incorporation | 1.39B |
| AViTA | 1.20B |
| NaviFUS | 1.20B |
| Rossmax International | 1.11B |
| Wiltrom | 1.08B |
| Cowealth Medical Holding | 1.06B |
| S&S Healthcare Holding | 1.01B |